ARF promotes MDM2 degradation and stabilizes p53: ARF-INK4a locus deletion impairs both the Rb and p53 tumor suppression pathways
- PMID: 9529249
- DOI: 10.1016/s0092-8674(00)81401-4
ARF promotes MDM2 degradation and stabilizes p53: ARF-INK4a locus deletion impairs both the Rb and p53 tumor suppression pathways
Abstract
The INK4a-ARF locus encodes two unrelated proteins that both function in tumor suppression. p16INK4 binds to and inhibits the activity of CDK4 and CDK6, and ARF arrests the cell cycle in a p53-dependent manner. We show here that ARF binds to MDM2 and promotes the rapid degradation of MDM2. This interaction is mediated by the exon 1beta-encoded N-terminal domain of ARF and a C-terminal region of MDM2. ARF-promoted MDM2 degradation is associated with MDM2 modification and concurrent p53 stabilization and accumulation. The functional consequence of ARF-regulated p53 levels via MDM2 proteolysis is evidenced by the ability of ectopically expressed ARF to restore a p53-imposed G1 cell cycle arrest that is otherwise abrogated by MDM2. Thus, deletion of the ARF-INK4a locus simultaneously impairs both the INK4a-cyclin D/CDK4-RB and the ARF-MDM2-p53 pathways.
Similar articles
-
Mutations in human ARF exon 2 disrupt its nucleolar localization and impair its ability to block nuclear export of MDM2 and p53.Mol Cell. 1999 May;3(5):579-91. doi: 10.1016/s1097-2765(00)80351-2. Mol Cell. 1999. PMID: 10360174
-
Growth suppression by a p14(ARF) exon 1beta adenovirus in human tumor cell lines of varying p53 and Rb status.Cancer Gene Ther. 2002 Oct;9(10):830-9. doi: 10.1038/sj.cgt.7700505. Cancer Gene Ther. 2002. PMID: 12224024
-
The alternative product from the human CDKN2A locus, p14(ARF), participates in a regulatory feedback loop with p53 and MDM2.EMBO J. 1998 Sep 1;17(17):5001-14. doi: 10.1093/emboj/17.17.5001. EMBO J. 1998. PMID: 9724636 Free PMC article.
-
The INK4a/ARF tumor suppressor: one gene--two products--two pathways.Trends Biochem Sci. 1998 Aug;23(8):291-6. doi: 10.1016/s0968-0004(98)01236-5. Trends Biochem Sci. 1998. PMID: 9757829 Review.
-
The Pezcoller lecture: cancer cell cycles revisited.Cancer Res. 2000 Jul 15;60(14):3689-95. Cancer Res. 2000. PMID: 10919634 Review.
Cited by
-
Hemizygous deletion of cyclin-dependent kinase inhibitor 2A/B with p16 immuno-negative and methylthioadenosine phosphorylase retention predicts poor prognosis in IDH-mutant adult glioma.Neurooncol Adv. 2024 May 8;6(1):vdae069. doi: 10.1093/noajnl/vdae069. eCollection 2024 Jan-Dec. Neurooncol Adv. 2024. PMID: 39022644 Free PMC article.
-
Potential roles of UCH family deubiquitinases in tumorigenesis and chemical inhibitors developed against them.Am J Cancer Res. 2024 Jun 15;14(6):2666-2694. doi: 10.62347/OEGE2648. eCollection 2024. Am J Cancer Res. 2024. PMID: 39005671 Free PMC article. Review.
-
The cell cycle regulator p16 promotes tumor infiltrated CD8+ T cell exhaustion and apoptosis.Cell Death Dis. 2024 May 15;15(5):339. doi: 10.1038/s41419-024-06721-7. Cell Death Dis. 2024. PMID: 38750022 Free PMC article.
-
Understanding the complexity of p53 in a new era of tumor suppression.Cancer Cell. 2024 Jun 10;42(6):946-967. doi: 10.1016/j.ccell.2024.04.009. Epub 2024 May 9. Cancer Cell. 2024. PMID: 38729160 Free PMC article. Review.
-
Soft Tissue Sarcomas with Chromosomal Alterations in the 12q13-15 Region: Differential Diagnosis and Therapeutic Implications.Cancers (Basel). 2024 Jan 19;16(2):432. doi: 10.3390/cancers16020432. Cancers (Basel). 2024. PMID: 38275873 Free PMC article. Review.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases
Research Materials
Miscellaneous
